Discover my current regimen (since August 2015) more info

Seborrheic Dermatitis vs Psoriasis: Causes, Symptoms and Treatments

Seborrheic dermatitis and psoriasis are two common inflammatory skin conditions that share some similar symptoms but have important differences. Both conditions can significantly impact quality of life if left untreated [1]. However, they require different treatment approaches. As such, correctly distinguishing between seborrheic dermatitis and the various types of psoriasis is critical for effective management.

This article will provide an in-depth examination of seborrheic dermatitis and psoriasis to highlight their key characteristics. It will outline the methods used by doctors to tell them apart and summarize the implications of misdiagnosis. The article concludes with practical lifestyle measures patients can take to alleviate symptoms alongside medical treatment.

In-Depth Look at Seborrheic Dermatitis

Seborrheic dermatitis is a chronic skin condition marked by flaking, scaling, and erythema (redness) [2]. It most often affects sebum-rich areas including the scalp, central face, and upper back.

Symptoms and Progression

The most common symptoms are [3]:

  • Red, greasy skin covered with flaky white or yellow scales
  • Patches of dry, irritated skin
  • Itchiness and burning sensation

Onset is typically gradual. Symptoms may fluctuate in severity and worsen with stress or changes in hormone levels [4]. Without treatment, symptoms persist long-term with periodic flares.

Infants within the first 3-4 months of life commonly get cradle cap. This form clears spontaneously after about a year [4]. Seborrheic dermatitis then reappears during puberty, persisting through adulthood with peak severity after age 50 [4].

Treatment Approach

First-line treatments are topical antifungal agents containing ketoconazole, zinc pyrithione, selenium sulfide, or salicylic acid [5]. These help curb colonization of Malassezia yeasts implicated in seborrheic dermatitis [6].

For more resistant cases, topical corticosteroids and calcineurin inhibitors may be prescribed alongside antifungals. Phototherapy is another option. Dietary modifications to exclude food triggers can help reduce flare-ups.

With appropriate treatment, seborrheic dermatitis can be controlled though difficult to completely cure [1]. Periodic returns of symptoms are common, especially with fluctuations in immune status, stress levels, or hormonal changes [3].

In-Depth Look at Psoriasis

Psoriasis is an autoimmune condition causing rapid buildup of skin cells. This results in inflamed, scaly plaques on the skin’s surface [7].

Symptoms and Progression

The most characteristic signs are [8]:

  • Patches of red, scaly, inflamed skin
  • Silvery-white scales or plaque buildup on affected areas
  • Pitting, splitting, or loosening of fingernails and toenails
  • Joint pain, stiffness, and swelling (psoriatic arthritis)

In most cases, psoriasis follows a relapsing-remitting course with disease flares interspersed by periods of remission. Once diagnosed, psoriasis is generally lifelong though individual prognosis varies [9].

Types of Psoriasis

There are several variants of psoriasis to distinguish:

Plaque psoriasis – The most common form (90% of cases) marked by raised, inflamed lesions covered with silvery-white scales typically occurring on the knees, elbows, scalp, and torso [10].

Guttate psoriasis – Small, drop-shaped sores appear on the trunk, arms, legs, and scalp. Often follows a bacterial throat infection. Tends to resolve spontaneously after several weeks [11].

Inverse/flexural psoriasis – Smooth, red lesions form in skin folds around genitals, armpits, and under the breasts or buttocks. Lack the thick scale seen in plaque psoriasis due to moisture, friction, and absence of air.

Pustular psoriasis – White, pus-filled blisters surrounded by red skin. Tends to have cyclical flares. Can be life-threatening if widespread due to loss of skin barrier. Requires urgent treatment [12].

Erythrodermic psoriasis – Severe, widespread inflammation and exfoliation of most of the skin’s surface. Can develop suddenly in plaque psoriasis or from withdrawal of corticosteroid treatment. Causes life-threatening protein and fluid loss.

Treatment Approach

Topical agents remain first-line therapy for mild to moderate psoriasis:

  • Corticosteroids – Powerful anti-inflammatory effect but risks skin damage with long-term use [13].
  • Vitamin D analogs – Help normalize excessive growth of skin cells [14].
  • Tazarotene – Synthetic retinoid that reduces inflammation.
  • Anthralin – Suppresses skin cell turnover [15].
  • Moisturizers – Soothe and hydrate irritated skin.

For moderate to severe cases, phototherapy with controlled doses of UV light helps dampen skin cell overproduction and inflammation [16].

Oral or injectable systemic medications like methotrexate, cyclosporine, and biologic agents directly target pathological inflammatory pathways in psoriasis. However, these treatments require careful monitoring for cumulative organ toxicity and side effects [9].

Direct Comparison: Seborrheic Dermatitis vs Psoriasis

Despite some visual resemblance, seborrheic dermatitis and psoriasis differ in their underlying mechanisms, distribution patterns, and triggers.

Seborrheic Dermatitis Psoriasis
Pathogenesis Exaggerated skin reaction to commensal yeast (Malassezia spp.) [6] Autoimmune disorder causing epidermal hyperplasia and inflammation mediated by IL-17/IL-23 pathway [7]
Characteristics Greasy, yellow scales with underlying redness Thick silvery-white scales with well-demarcated borders
Locations Central face, scalp, upper back, and chest. Spares distal limbs. Variable. Commonly knees, elbows, trunk, and scalp. Can occur anywhere. Nail changes only in psoriasis.
Course Fluctuating symptoms with periodic flares. Chronic relapsing course.
Triggers Changes in sebum production, humidity, skin pH alterations, stress, immunosuppression Genetic predisposition with possible environmental triggers like infections, medication, skin trauma, stress, and cold weather [17, 18].
Associated conditions Higher rates of metabolic disease and depression [1] Psoriatic arthritis (10-30% cases) [19]. Increased cardiovascular risks. High psychiatric comorbidity.
Treatment Topical antifungals, topical steroids. Oral antifungals rarely needed. Topical therapies, phototherapy, and systemic immunomodulators like methotrexate, cyclosporine, biologics depending on severity.
Prognosis Persisting, difficult to cure. Controlled with maintenance treatment. Lifelong condition with alternating remissions and flares. Prognosis variable.

Scalp Involvement: Seborrheic Dermatitis vs Psoriasis

Seborrheic dermatitis presents as greasy yellow flakes with underlying redness. Hair damage is generally reversible.

Key features:

  • Mild to moderate scaling
  • Itchiness is common
  • No permanent hair loss
  • Treatment involves topical antifungals, intermittent topical steroids [2]

Scalp psoriasis causes thick, clearly demarcated silvery plaques that bleed easily. Risk of permanent hair loss is higher.

Key features:

  • Dense, adherent scales
  • Increased fragility and breakage of hair [10]
  • Higher rates of hair loss
  • Potential psoriatic arthritis [19]
  • Phototherapy, vitamin D derivatives, and topical steroids more often needed [13]

Distinguishing features aid diagnosis of ambiguous cases:

Seborrheic Dermatitis Scalp Psoriasis
Milder inflammation [20] Thick plaques [9]
Greasy yellow scales Prominent silvery scales [10]
Central involvement on scalp Any site on scalp [8]
Reversible hair changes Higher rates of permanent hair loss [10]
Rarely itchy [2] Frequent itch [9]
No joint complaints May have psoriatic arthritis [19]

Misdiagnosis and Its Risks

Distinguishing seborrheic dermatitis from plaque psoriasis or scalp psoriasis can be challenging. However, incorrect diagnosis impairs effective treatment.

Due to its greasy scales and facial involvement, seborrheic dermatitis is sometimes mistaken for scalp psoriasis. Meanwhile, psoriasis on the body may be misidentified as seborrheic dermatitis. This is especially true with inverse and flexural psoriasis in the absence of thick plaques.

Misdiagnosing seborrheic dermatitis as psoriasis often prompts prescription of inappropriate systemic therapies or UVR phototherapy with their attendant side effects [21]. These aggressive treatments offer little added benefit if skin inflammation is actually driven by yeast overgrowth instead of autoimmunity.

Conversely, wrongly dismissing psoriatic disease delays initiating treatment to target IL-17 mediated inflammation early on. Unchecked disease can lead to cumulative damage to skin and joints as well as adverse physical and psychosocial sequelae. Distinguishing other variants like pustular and erythrodermic psoriasis is also critical given their potential to cause life-threatening electrolyte abnormalities [12].

Careful history taking and physical examination aids diagnosis by eliciting differences between their common sites of involvement, triggers and associated illnesses. Tricky cases may need skin biopsy or trial of antifungal therapy to rule out seborrheic dermatitis masquerading as one of the scaly eruptions of psoriasis.

Living with Seborrheic Dermatitis and Psoriasis

Coping with chronic inflammatory skin disease poses physical and emotional challenges for patients. Lifestyle measures to reduce flare triggers and optimize disease control are important adjuncts to medical therapy.

Lifestyle Adaptations

The following lifestyle strategies may help reduce symptoms:

  • Stress management – Try relaxation techniques, counseling, or support groups to mitigate anxiety and depression.
  • Avoid skin irritants – Use gentle cleansers. Wear smooth fabrics, avoid wool and synthetic materials.
  • Moisturize skin – Apply fragrance-free moisturizers after bathing. Ointments seal in moisture better than lotions.
  • Control alcohol intake – Alcohol can promote inflammation and interacts with some systemic psoriasis medication.
  • Quit smoking – Smoking increases the risk for both conditions and may initiate disease in genetically predisposed people.
  • Address infections – Promptly treat strep infections to help prevent guttate flares. Avoid unnecessary antibiotics when possible.
  • Improve diet quality – An anti-inflammatory diet rich in produce, fibers, and omega-3 fatty acids may help dampen symptoms.
  • Optimize vitamin D – Low vitamin D worsens several autoimmune conditions. Use sun protection but ensure adequate daily intake through UV exposure, fortified foods, or supplementation.
  • Consider supplements – Herbal remedies like aloe vera, milk thistle, or curcumin may provide relief for some people, but clinical evidence is still limited overall.

Emotional and Psychological Impacts

Visible skin lesions and accompanying itch or soreness often significantly detracts from emotional wellbeing and body image. Confronting public misconceptions poses an added challenge.

Seeking social support, whether from loved ones, patient advocacy groups or mental health professionals, validates experiences and fosters resilience. While symptoms wax and wane, self-care underpins the ability to cope with disease fluctuations. Partners can provide invaluable empathy and assistance with treatment.


In summary, psoriasis and seborrheic dermatitis are two distinct dermatologic disorders with important differences in their characteristics and management considerations.

Misdiagnosis between plaque psoriasis or scalp psoriasis and seborrheic dermatitis is common. Clinical evaluation together with skin biopsy helps distinguish ambiguous cases. Correctly delineating between these conditions ensures appropriate treatment to attain disease control and improve patient quality of life.

Lifestyle measures like stress reduction techniques, skin protection, dietary improvements and positive social support work hand-in-hand with medical therapy to help sufferers better adjust to living with chronic skin disease.

Future research elucidating the role of skin and gut microbiota in propagating inflammation will uncover additional avenues for treatment advancements.


  1. R R Warner, J R Schwartz, Y Boissy, T L Dawson "Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo." Journal of the American Academy of Dermatology 45.6 (2001): 897-903. PubMed
  2. James Q Del Rosso "Adult seborrheic dermatitis: a status report on practical topical management." The Journal of clinical and aesthetic dermatology 4.5 (2011): 32-8. PubMed
  3. Boni E Elewski "Clinical diagnosis of common scalp disorders." The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 10.3 (2005): 190-3. PubMed
  4. Aditya K Gupta, Robyn Bluhm, Elizabeth A Cooper, Richard C Summerbell, Roma Batra "Seborrheic dermatitis." Dermatologic clinics 21.3 (2003): 401-12. PubMed
  5. Robert A Bacon, Haruko Mizoguchi, James R Schwartz "Assessing therapeutic effectiveness of scalp treatments for dandruff and seborrheic dermatitis, part 2: the impact of gender and ethnicity on efficacy." The Journal of dermatological treatment 25.3 (2013): 237-40. PubMed
  6. Byung In Ro, Thomas L Dawson "The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff." The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 10.3 (2005): 194-7. PubMed
  7. Paola Di Meglio, Federica Villanova, Frank O Nestle "Psoriasis." Cold Spring Harbor perspectives in medicine 4.8 (2015). PubMed
  8. E M Farber, M L Nall "The natural history of psoriasis in 5,600 patients." Dermatologica 148.1 (1974): 1-18. PubMed
  9. Wolf-Henning Boehncke, Michael P Schön "Psoriasis." Lancet (London, England) 386.9997 (2015): 983-94. PubMed
  10. Jp Ortonne, S Chimenti, T Luger, L Puig, F Reid, R M Trüeb "Scalp psoriasis: European consensus on grading and treatment algorithm." Journal of the European Academy of Dermatology and Venereology : JEADV 23.12 (2010): 1435-44. PubMed
  11. H J WHYTE, R D BAUGHMAN "ACUTE GUTTATE PSORIASIS AND STREPTOCOCCAL INFECTION." Archives of dermatology 89 (1996): 350-6. PubMed
  12. Eugenia Shmidt, David A Wetter, Sara B Ferguson, Mark R Pittelkow "Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010." Journal of the American Academy of Dermatology 67.5 (2013): e179-85. PubMed
  13. M Lebwohl, P T Ting, J Y M Koo "Psoriasis treatment: traditional therapy." Annals of the rheumatic diseases 64 Suppl 2.Suppl 2 (2005): ii83-6. PubMed
  14. K Kragballe, B T Gjertsen, D De Hoop, T Karlsmark, P C van de Kerkhof, O Larkö, C Nieboer, J Roed-Petersen, A Strand, G Tikjøb "Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris." Lancet (London, England) 337.8735 (1991): 193-6. PubMed
  15. N J Lowe, R E Ashton, H Koudsi, M Verschoore, H Schaefer "Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin." Journal of the American Academy of Dermatology 10.1 (1984): 69-72. PubMed
  16. R S Stern, N Laird, J Melski, J A Parrish, T B Fitzpatrick, H L Bleich "Cutaneous squamous-cell carcinoma in patients treated with PUVA." The New England journal of medicine 310.18 (1984): 1156-61. PubMed
  17. Shanu Kohli Kurd, Andrea B Troxel, Paul Crits-Christoph, Joel M Gelfand "The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study." Archives of dermatology 146.8 (2010): 891-5. PubMed
  18. H Devrimci-Ozguven, T N Kundakci, H Kumbasar, A Boyvat "The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients." Journal of the European Academy of Dermatology and Venereology : JEADV 14.4 (2001): 267-71. PubMed
  19. Ilaria Ruffilli, Francesca Ragusa, Salvatore Benvenga, Roberto Vita, Alessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari "Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity." Frontiers in endocrinology 8 (2017): 139. PubMed
  20. R S Berger, M F Stoner, E R Hobbs, T J Hayes, R N Boswell "Cutaneous manifestations of early human immunodeficiency virus exposure." Journal of the American Academy of Dermatology 19.2 Pt 1 (1988): 298-303. PubMed
  21. A L Buchman "Side effects of corticosteroid therapy." Journal of clinical gastroenterology 33.4 (2001): 289-94. PubMed
Last Updated:
in Psoriasis, Seborrheic Dermatitis   0

About Michael Anders

After being affected by seborrheic dermatitis, I have made it my goal to gather and organize all the information that has helped me in my journey.

Share Your Thoughts

(will not be published)

No Comments

Be the first to start a conversation